182 related articles for article (PubMed ID: 27010858)
1. ARHGAP10, downregulated in ovarian cancer, suppresses tumorigenicity of ovarian cancer cells.
Luo N; Guo J; Chen L; Yang W; Qu X; Cheng Z
Cell Death Dis; 2016 Mar; 7(3):e2157. PubMed ID: 27010858
[TBL] [Abstract][Full Text] [Related]
2. ARHGAP10, Transcriptionally Regulated by Sodium Butyrate, Promotes Ferroptosis of Ovarian Cancer Cells.
Ke H; Shao J; Hu J; Song X; Han H; Zhu Z; Zhou X; Chen L; Shan Y
Front Biosci (Landmark Ed); 2024 Apr; 29(5):167. PubMed ID: 38812318
[TBL] [Abstract][Full Text] [Related]
3. CXCL12 promotes human ovarian cancer cell invasion through suppressing ARHGAP10 expression.
Luo N; Chen DD; Liu L; Li L; Cheng ZP
Biochem Biophys Res Commun; 2019 Oct; 518(3):416-422. PubMed ID: 31445707
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of TMEM45A suppresses proliferation, induces cell cycle arrest and reduces cell invasion in human ovarian cancer cells.
Guo J; Chen L; Luo N; Yang W; Qu X; Cheng Z
Oncol Rep; 2015 Jun; 33(6):3124-30. PubMed ID: 25872785
[TBL] [Abstract][Full Text] [Related]
5. Knockdown of anion exchanger 2 suppressed the growth of ovarian cancer cells via mTOR/p70S6K1 signaling.
Zhang LJ; Lu R; Song YN; Zhu JY; Xia W; Zhang M; Shao ZY; Huang Y; Zhou Y; Zhang H; Guo L; Zhang M; Zhang H
Sci Rep; 2017 Jul; 7(1):6362. PubMed ID: 28743911
[TBL] [Abstract][Full Text] [Related]
6. ARHGAP10, which encodes Rho GTPase-activating protein 10, is a novel gene for schizophrenia risk.
Sekiguchi M; Sobue A; Kushima I; Wang C; Arioka Y; Kato H; Kodama A; Kubo H; Ito N; Sawahata M; Hada K; Ikeda R; Shinno M; Mizukoshi C; Tsujimura K; Yoshimi A; Ishizuka K; Takasaki Y; Kimura H; Xing J; Yu Y; Yamamoto M; Okada T; Shishido E; Inada T; Nakatochi M; Takano T; Kuroda K; Amano M; Aleksic B; Yamomoto T; Sakuma T; Aida T; Tanaka K; Hashimoto R; Arai M; Ikeda M; Iwata N; Shimamura T; Nagai T; Nabeshima T; Kaibuchi K; Yamada K; Mori D; Ozaki N
Transl Psychiatry; 2020 Jul; 10(1):247. PubMed ID: 32699248
[TBL] [Abstract][Full Text] [Related]
7. miR-185 targets RhoA and Cdc42 expression and inhibits the proliferation potential of human colorectal cells.
Liu M; Lang N; Chen X; Tang Q; Liu S; Huang J; Zheng Y; Bi F
Cancer Lett; 2011 Feb; 301(2):151-60. PubMed ID: 21186079
[TBL] [Abstract][Full Text] [Related]
8. SMURF1-mediated ubiquitination of ARHGAP26 promotes ovarian cancer cell invasion and migration.
Chen X; Chen S; Li Y; Gao Y; Huang S; Li H; Zhu Y
Exp Mol Med; 2019 Apr; 51(4):1-12. PubMed ID: 31004081
[TBL] [Abstract][Full Text] [Related]
9. The human orthologue of CdGAP is a phosphoprotein and a GTPase-activating protein for Cdc42 and Rac1 but not RhoA.
Tcherkezian J; Triki I; Stenne R; Danek EI; Lamarche-Vane N
Biol Cell; 2006 Aug; 98(8):445-56. PubMed ID: 16519628
[TBL] [Abstract][Full Text] [Related]
10. Regulation and functional significance of CDC42 alternative splicing in ovarian cancer.
He X; Yuan C; Yang J
Oncotarget; 2015 Oct; 6(30):29651-63. PubMed ID: 26336992
[TBL] [Abstract][Full Text] [Related]
11. [ARHGAP10, a novel RhoGAP at the cross-road between ARF1 and Cdc42 pathways, regulates Arp2/3 complex and actin dynamics on Golgi membranes].
Dubois T; Chavrier P
Med Sci (Paris); 2005; 21(8-9):692-4. PubMed ID: 16115449
[No Abstract] [Full Text] [Related]
12. Downregulation of glypican-3 expression increases migration, invasion, and tumorigenicity of human ovarian cancer cells.
Liu Y; Zheng D; Liu M; Bai J; Zhou X; Gong B; Lü J; Zhang Y; Huang H; Luo W; Huang G
Tumour Biol; 2015 Sep; 36(10):7997-8006. PubMed ID: 25967456
[TBL] [Abstract][Full Text] [Related]
13. ZFP403, a novel tumor suppressor, inhibits the proliferation and metastasis in ovarian cancer.
Zhu Z; Lou C; Zheng Z; Zhu R; Tian S; Xie C; Zhao H
Gynecol Oncol; 2017 Nov; 147(2):418-425. PubMed ID: 28864131
[TBL] [Abstract][Full Text] [Related]
14. Knockdown of RhoA expression alters ovarian cancer biological behavior in vitro and in nude mice.
Wang X; Jiang W; Kang J; Liu Q; Nie M
Oncol Rep; 2015 Aug; 34(2):891-9. PubMed ID: 26035556
[TBL] [Abstract][Full Text] [Related]
15. miR-137 targets Cdc42 expression, induces cell cycle G1 arrest and inhibits invasion in colorectal cancer cells.
Liu M; Lang N; Qiu M; Xu F; Li Q; Tang Q; Chen J; Chen X; Zhang S; Liu Z; Zhou J; Zhu Y; Deng Y; Zheng Y; Bi F
Int J Cancer; 2011 Mar; 128(6):1269-79. PubMed ID: 20473940
[TBL] [Abstract][Full Text] [Related]
16. ARHGAP24 inhibits cell proliferation and cell cycle progression and induces apoptosis of lung cancer via a STAT6-WWP2-p27 axis.
Wang L; Shen S; Xiao H; Ding F; Wang M; Li G; Hu F
Carcinogenesis; 2020 Jul; 41(5):711-721. PubMed ID: 31430374
[TBL] [Abstract][Full Text] [Related]
17. Identification of "regulation of RhoA activity panel" as a prognostic and predictive biomarker for gastric cancer.
Huang W; Zhao S; Zhang C; Li Z; Ge S; Lian B; Feng H; Wang K; Xu R; Ji J; Gao J; Shi W; Shen L
Aging (Albany NY); 2020 Dec; 13(1):714-734. PubMed ID: 33288739
[TBL] [Abstract][Full Text] [Related]
18. Snail regulates the motility of oral cancer cells via RhoA/Cdc42/p-ERM pathway.
Li YY; Zhou CX; Gao Y
Biochem Biophys Res Commun; 2014 Sep; 452(3):490-6. PubMed ID: 25172658
[TBL] [Abstract][Full Text] [Related]
19. The role of Sox6 and Netrin-1 in ovarian cancer cell growth, invasiveness, and angiogenesis.
Li Y; Xiao M; Guo F
Tumour Biol; 2017 May; 39(5):1010428317705508. PubMed ID: 28475012
[TBL] [Abstract][Full Text] [Related]
20. Mice carrying a schizophrenia-associated mutation of the Arhgap10 gene are vulnerable to the effects of methamphetamine treatment on cognitive function: association with morphological abnormalities in striatal neurons.
Hada K; Wulaer B; Nagai T; Itoh N; Sawahata M; Sobue A; Mizoguchi H; Mori D; Kushima I; Nabeshima T; Ozaki N; Yamada K
Mol Brain; 2021 Jan; 14(1):21. PubMed ID: 33482876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
